GEORGE R BLUMENSCHEIN's research topics

GEORGE R BLUMENSCHEIN

Concepts (663)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with GEORGE R BLUMENSCHEIN's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that GEORGE R BLUMENSCHEIN has written about over time.

Breast Neoplasms, 149 publications between 1976 and 2017, average publication date March 1983. Antineoplastic Agents, 73 publications between 1977 and 2018, average publication date April 1992. Aged, 176 publications between 1976 and 2024, average publication date September 1996. Antineoplastic Combined Chemotherapy Protocols, 83 publications between 1982 and 2023, average publication date July 2002. Angiogenesis Inhibitors, 8 publications between 2002 and 2013, average publication date August 2008. Neoplasm Recurrence, Local, 29 publications between 1981 and 2023, average publication date June 2009. Benzenesulfonates, 4 publications between 2008 and 2011, average publication date January 2010. Niacinamide, 9 publications between 2008 and 2013, average publication date January 2011. Paclitaxel, 17 publications between 2002 and 2019, average publication date June 2011. Indoles, 6 publications between 2009 and 2013, average publication date July 2011. Carboplatin, 17 publications between 2004 and 2019, average publication date October 2011. ErbB Receptors, 19 publications between 2004 and 2022, average publication date November 2012. Quinazolines, 14 publications between 2005 and 2022, average publication date February 2013. Lung Neoplasms, 95 publications between 1982 and 2024, average publication date May 2013. Carcinoma, Squamous Cell, 21 publications between 2007 and 2021, average publication date March 2014. Carcinoma, Non-Small-Cell Lung, 85 publications between 2002 and 2024, average publication date August 2014. Head and Neck Neoplasms, 16 publications between 2007 and 2023, average publication date March 2017. Antineoplastic Agents, Immunological, 10 publications between 2017 and 2021, average publication date March 2019.

Breast Neoplasms
Antineoplastic Agents
Aged
Antineoplastic Combined Chemotherapy Protocols
Angiogenesis Inhibitors
Neoplasm Recurrence, Local
Benzenesulfonates
Niacinamide
Paclitaxel
Indoles
Carboplatin
ErbB Receptors
Quinazolines
Lung Neoplasms
Carcinoma, Squamous Cell
Carcinoma, Non-Small-Cell Lung
Head and Neck Neoplasms
Antineoplastic Agents, Immunological

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Breast Neoplasms	149	1976	2017	March 1983
Antineoplastic Agents	73	1977	2018	April 1992
Aged	176	1976	2024	September 1996
Antineoplastic Combined Chemotherapy Protocols	83	1982	2023	July 2002
Angiogenesis Inhibitors	8	2002	2013	August 2008
Neoplasm Recurrence, Local	29	1981	2023	June 2009
Benzenesulfonates	4	2008	2011	January 2010
Niacinamide	9	2008	2013	January 2011
Paclitaxel	17	2002	2019	June 2011
Indoles	6	2009	2013	July 2011
Carboplatin	17	2004	2019	October 2011
ErbB Receptors	19	2004	2022	November 2012
Quinazolines	14	2005	2022	February 2013
Lung Neoplasms	95	1982	2024	May 2013
Carcinoma, Squamous Cell	21	2007	2021	March 2014
Carcinoma, Non-Small-Cell Lung	85	2002	2024	August 2014
Head and Neck Neoplasms	16	2007	2023	March 2017
Antineoplastic Agents, Immunological	10	2017	2021	March 2019

BLUMENSCHEIN's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (663)

Explore

Co-Authors (183)

Explore

Similar People (60)

Explore

Same Department

Explore